GlaxoSmithKline to pay $20 million to settle foreign bribery related charges

WASHINGTON (Reuters) – GlaxoSmithKline will pay $20 million to settle civil charges that it masked improper bribes to foreign officials in China on its books by disguising them as legitimate travel, entertainment and marketing expenses, U.S. regulators said Friday.